vTv Therapeutics Inc.
VTVT
$21.70
-$1.04-4.57%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1,385.71% | -91.81% | |||
| Gross Profit | -1,385.71% | 86.84% | |||
| SG&A Expenses | -11.68% | -6.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.07% | 7.97% | |||
| Operating Income | 9.07% | -27.15% | |||
| Income Before Tax | 8.88% | -8.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.88% | -6.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -14.00% | 6.50% | |||
| Net Income | 7.66% | -6.47% | |||
| EBIT | 9.07% | -27.15% | |||
| EBITDA | 9.09% | -27.24% | |||
| EPS Basic | 14.01% | -6.48% | |||
| Normalized Basic EPS | 13.03% | -9.09% | |||
| EPS Diluted | 14.01% | -6.48% | |||
| Normalized Diluted EPS | 13.03% | -9.09% | |||
| Average Basic Shares Outstanding | 7.37% | 0.00% | |||
| Average Diluted Shares Outstanding | 7.37% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
